FDA Brief

Warning letters Drugs

FDA warning letter to

AAA Cosmetica, SA de CV

High riskIssued Feb 3, 2021Posted Feb 9, 2021Center for Drug Evaluation and Research | CDER

Mexico-based hand sanitizer maker AAA Cosmetica shipped product labeled 70% ethanol that contained no ethanol and up to 81% methanol, FDA says.

What happened

FDA tested batches of bio aaa ADVANCE HAND SANITIZER after the shipment was detained and refused admission at the U.S. border. The label said the product contained 70% ethanol, but the lab found 0% ethanol and an average of 78 to 81% methanol, a toxic chemical not allowed in hand sanitizers. FDA also found the label's ethanol claim false and the methanol undeclared; the firm recalled one brand in July 2020 but did not recall other lots made at the same facility.

What FDA found

  1. The active ingredient ethanol was replaced wholly or in part with methanol, a dangerous chemical.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. The substitution shows that quality assurance at the facility is not working as CGMP (current good manufacturing practice) requires.

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  3. The product is an unapproved new drug sold without an FDA-approved application and does not fit the conditions for marketing without one.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  4. The label claims 70% ethanol but the product had far less and hid the methanol, so the labeling is false or misleading.

    FD&C Act section 502(a), 21 U.S.C. 352(a)
  5. The label does not list methanol as an ingredient.

    FD&C Act section 502(e)(1)(A), 21 U.S.C. 352(e)(1)(A)
  6. The product is dangerous to health when used as labeled because of the methanol.

    FD&C Act section 502(j), 21 U.S.C. 352(j)

What FDA wants

FDA asks the firm to reply in writing within 15 working days with a full investigation of the methanol substitution, the related CGMP failures and corrective actions, a list of raw materials and suppliers, a list of all batches shipped to the U.S. with reconciliation, complete batch records, a commitment to test every ethanol lot for methanol using the USP method, and an independent review of its laboratory. FDA also says the firm should request a regulatory meeting if it wants to ship drugs to the U.S. again; all its drugs remain on Import Alert 66-78.

Who should pay attention

  • distributors and retailers that sold any lots of this firm's hand sanitizer
  • brands that contract hand sanitizer manufacturing in Mexico
  • companies that buy ethanol from new or unverified suppliers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk